Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

Archer Limited : New shares issued

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, IN WHOLE OR IN PART DIRECTLY OR INDIRECTLY, IN AUSTRALIA, CANADA, JAPAN OR THE UNITED STATES OR ANY OTHER JURISDICTION IN WHICH THE RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. Archer Limited: New shares issued Reference is made to the previous stock exchange notices published in connection with the private placement (the "Private Placement") of 84,000,000 new shares (the "New Shares") in Archer Limited (OSE: ARCHER) (the "Company"). The

Dutch multi-site hospital invests in imaging IT solution from Sectra

Linköping, Sweden, March 3, 2017 - International medical imaging IT and cybersecurity company Sectra  (STO: SECT B) has signed a ten-year contract with Isala Hospital, in the Netherlands. The contract comprises Sectra’s IT solution for reviewing diagnostic images. The solution enables physicians at Isala Hospital to access and review medical images from any of its two hospitals, regardless of where current and prior images were taken. The joint solution also enables the two sites to efficiently share resources.Isala Hospital’s two facilities are located in the Dutch

ChromoGenics issue of new shares oversubscribed - brings in 117.3 MSEK and more than 2 000 new shareholders

ChromoGenics AB brings in 117.3 MSEK and more than 2 000 new shareholders through a now completed issue of new shares in combination with the company’s plan to list at Nasdaq First North Stockholm March 23rd 2017.The issue of new shares in ChromoGenics has been well received in the market and the board has decided to allocate about 119 MSEK, of which 117.3 MSEK correspond to the basic offer that will be added to ChromoGenics, before deduction of issue expenses and settlements of shareholder loans and guarantee fees. Excess amounts may be subject to normal market stabilization and / or

Presentation of the result of Medivir’s voluntary redemption programme

Stockholm, Sweden – Medivir AB (Nasdaq Stockholm: MVIR) today announces the result of Medivir’s voluntary redemption programme. The redemption programme comprised a total of 6,738,655 shares in Medivir. Upon completion of the application period, a total of 6,647,060 shares have been registered for redemption, whereof 131,589 series A shares and 6,515,471 series B shares, corresponding to an acceptance level of 98.6 per cent. In total, cash proceeds of approximately SEK 857.5 million will be distributed to the shareholders, corresponding to SEK 129 per redeemed share, to be paid around 24

Jon James appointed new CEO of Tele2 Netherlands and member of Tele2 AB’s Leadership Team

Stockholm – Tele2 AB, (Tele2), (NASDAQ OMX Stockholm: TEL2 A and TEL2 B) today announces that Jonathan (Jon) James is appointed new CEO of Tele2 Netherlands and member of Tele2 AB’s Leadership Team. Jon succeeds Malin Holmberg who will leave the company.Jon James was most recently COO at Swedish cable operator Com Hem, where he led the consumer business through a successful transformation. He has over 20 years of experience within the media and telecom industry. Before joining Com Hem, Jon worked for the British operator Virgin Media where he led the company’s broadband and television

Opus Group closes acquisition in Córdoba, Argentina

On March 2, 2017, Opus’ Argentinian subsidiary, Opus Inspection SA, completed the acquisition of three vehicle inspection concessions in Córdoba, Argentina.  Opus began operating the three vehicle inspection stations in Córdoba on March 1, 2017.Opus acquired the concessions under an asset purchase agreement with Inspecentro, a Portuguese vehicle inspection company. A purchase price is not disclosed at this time due to competitive reasons. Mölndal, March 3, 2017Opus Group AB (publ)

Skanska invests in land in Prague, Czech Republic, for CZK 841M, about SEK 290M

Skanska has acquired land in Prague, Czech Republic, from Codeco UK. The total investment amounts to CZK 841M, about SEK 290M.The plot is a former brownfield situated in the district of Vysocany in Prague. Skanska is planning to develop it into an extensive residential area with good access to the city center. Skanska is one of the leading development and construction companies in Europe. Outside the Nordics the company has European operations in building construction and civil engineering in Poland, Czech Republic & Slovakia and UK. Skanska develops commercial properties in select home

Selvaag Bolig ASA: Purchase of treasury shares

Selvaag Bolig ASA purchased 7 407 treasury shares on 2 March 2017. The shares were purchased at an average price of NOK 39.79. The shares were purchased for the company's share programmes for employees. After the transaction, Selvaag Bolig owns 569 266 treasury shares. Further information fromSverre Molvik, CFO, Selvaag Bolig ASATelephone: +47 401 00 585, e-mail: smo@selvaagbolig.no Selvaag Bolig ASA is a residential property developer controlling the entire value chain from acquisition of land to sale of homes. The company has several thousand homes under development at any

MEDIMMUNE AND SANOFI PASTEUR FORM ALLIANCE TO DEVELOP AND COMMERCIALISE POTENTIAL NEXT-GENERATION RESPIRATORY SYNCYTIAL VIRUS ANTIBODY MEDI8897

This announcement contains inside information   3 March 2017 07:00 GMT MedImmune, the global biologics research and development arm of AstraZeneca, and Sanofi Pasteur, the vaccines division of Sanofi, today announced an agreement to develop and commercialise MEDI8897 jointly. MEDI8897 is a monoclonal antibody (mAb) for the prevention of lower respiratory tract illness (LRTI) caused by respiratory syncytial virus (RSV), the most prevalent cause of LRTI among infants and young children. MEDI8897 is currently in a Phase IIb clinical trial in pre-term infants who are ineligible for

Wihlborgs signs leases for Baltzar City in Malmö

In little time, Wihlborgs has signed leases with three new tenants at Baltzar City in Malmö. In total, the new leases comprise 1,600 m2.Baltzar City is located at the junction of Södergatan/Baltzargatan in central Malmö and on the ground floor there are stores, such as Stadium, Marlene Birger, Bitte Kai Rand, Holy Greens and others. The remaining floors comprise office premises with tenants including Skandia and Kvällsposten. The three new tenants, which will move into office space during the spring, are Espresso House, Twilio (formerly Beepsend) and Resurs Bank. “Baltzar City has an

Zaplox signs agreement with a Danish hotel chain

Zaplox AB (Zaplox) – market innovator of advanced mobile key services – has signed an agreement with a well-renowned Danish hotel chain. The Zaplox solution, among other things, provides check-in both with a mobile app and in so called virtual kiosks in the reception. It will be installed in a new hotel project, and the ambition is later to implement the Zaplox solution in all the hotel chain’s hotels in Denmark.Zaplox has signed an agreement with a major Danish hotel chain with hotels at premium locations. The agreement is the first of its kind, since it includes both a solution for mobile

Orkla ASA: Mandatory notification of trade - options

On 2 March, in connection with Orkla's former management option programme, 35,000 options in Orkla-shares were exercised at a strike price of NOK 40.03 per share. The transactions comprise primary insider Atle Vidar Nagel Johansen, Executive Vice President and CEO Orkla Foods. Nagel Johansen exercised 35,000 options at a strike price of NOK 40.03 per share, of which 30,800 shares were sold at a price of NOK 75.5246 per share. After this transaction, Nagel Johansen and close associates own 25,881 shares and no options in Orkla.After this transaction, the total number of options issued

Freedesk AB is planning a new share issue and listing on AktieTorget

At the meeting of the Board of Directors of Freedesk AB (“Freedesk”) held on March 2, 2017 it was decided that, with the authorization from the Annual General Meeting held on February 16, 2017, to issue new shares ahead its scheduled listing on AktieTorget. At full subscription to the new share issue, the company will receive an increase of capital in the amount of approx. SEK 12.5 million (before issuance costs). The listing on AktieTorget is scheduled to take place in late April 2017.Freedesk is a company that develops a wide range of simple and flexible products to promote a more active

Atea A/S («Atea Denmark», "the Company") has, as a legal entity, been prosecuted in a corruption case involving former employees’ actions

Reference is made to the former stock exchange notices regarding a potential corruption case involving Atea Denmark. On March 2, Atea Denmark was presented with a formal prosecution (norsk: tiltale) as the legally responsible entity, of bribery and embezzlement carried out by four former employees in the company, in a time period from 2009-2014. The prosecution against the Company was made simultaneously with the prosecution against the four persons involved. The same four persons were employed at Atea Denmark at the time the actions took place. As the Company has been prosecuted as a

thyssenkrupp’s Heritage, Innovation and Services on Display at 2017 CONEXPO-CON/AGG in Las Vegas

Company experts highlight latest industry offerings, from crushing equipment and conveying systems to undercarriages and track systems, in two booths – B91525 and C20327LAS VEGAS (March 2, 2017) – thyssenkrupp, the global technology and industrial group, will highlight its latest products, technology and solutions at CONEXPO-CON/AGG 2017 in Las Vegas, from Tuesday, March 7 through Saturday, March 11 at the Las Vegas Convention Center. As an established engineering, equipment, component and service provider, thyssenkrupp’s exhibits will focus on its capabilities for the construction,

OCY - Primary insider disclosure

Erøy AS, a company controlled by Øyvind Eriksen, President and CEO of Aker ASA, the majority shareholder of Ocean Yield ASA (the "Company"), has today acquired 200,000 shares in the Company at a purchase price of NOK 61.3534 per share.Following this transaction, Erøy AS holds 200,000 shares in the Company, constituting 0.13% of the Company's shares and votes. Laffen Holding AS, a company controlled by Olav Revhaug, general manager of TRG AS, Aker ASA's majority shareholder, has today acquired 100,000 shares in the Company at a purchase price of NOK 61.3534 per share. Following this

United Bankers Oyj: SHARE REPURCHASE 2.3.2017

United Bankers Oyj     STOCK EXCHANGE ANNOUNCEMENT    2.3.2017 SHARE REPURCHASE 2.3.2017 In the Helsinki Stock Exchange Trade date 2.3.2017Bourse trade BUYShare UNIAVAmount 100 sharesAverage price/ share 36.4000 EURTotal cost 3 640,00 EUR United bankers Oyj now holds a total of 7 937 sharesincluding the shares repurchased on 2.3.2017. On behalf of United Bankers Oyj Nordea Bank AB (publ), Finnish BranchJanne Sarvikivi         Julius Summanen

DELAY IN COMPLETION OF THE REFINANCING OF FINANCIAL OBLIGATIONS AND PROVISION OF NEW WORKING CAPITAL

The Board of Directors (the “Board”) of EMAS Offshore Limited (“EOL” or the “Company”, together with its subsidiaries and associated companies, the “Group”) refers to the announcement released by the Company dated 30 October 2016 where the Company announced that the Group has reached in- principle agreements with the substantial majority of its principal bankers on the refinancing of its financial obligations and the provision of additional working capital facilities (the “Ongoing Initiatives”). The Board wishes to state that the completion of the documentation for the Ongoing

Nytida starts construction of new housing in Mariefred

Next week, the construction starts of Ambea’s subsidiary Nytida’s new housing at Slottsbrinken in Mariefred. Builder is Bällstaudde Projektutveckling AB and the housing with six apartments will be ready approximately by February 2018.The housing is intended for people with neuropsychiatric diagnoses like autism and Asperger syndrome. It will be situated in a quiet area, with a large garden. The residents will have access to common areas and there will be a separate apartment for the staff. ─ We know that the need of housing for people with functional disabilities is growing. We bring our

SimCorp Webinar on Adox Research ‘Follow the Money’ Survey Reveals Front Office Data is ‘Broken’

A recent webinar held by SimCorp , a leading provider of investment management solutions  and services to the global financial services industry, in collaboration with Adox Research, a prominent technology research and advisory service, revealed that 79% of participants report at least 9% of inbound data in their front office is broken and requires manual repair. Out of this, 17% report that more than 20% of their data requires attention. The findings offer important insights into the technology challenges buy and sell side firms are currently

Veidekke ASA: PRESENTATION

Veidekke ASA would like to invite you to attend the presentation of its Economic Activity Report on the Scandinavian Building and Construction Markets to be held on Monday, 13 March at 12.30 p.m. at Veidekke headquarters in Skabos vei 4, Skøyen, Oslo. Lunch will be served from 12.00 noon. Please register with Anita Pettersen at anita.pettersen@veidekke.no or tel. +47 996 45 414 no later than, 8 March. This information is subject to the disclosure requirements pursuant to section 5 -12 of the Norwegian Securities Trading Act.

#17-198 Listing of Turbo warrants issued by BNP Paribas Arbitrage Issuance B.V.

As from March 03, 2017, 2 Turbo warrants issued by BNP Paribas Arbitrage Issuance B.V. will be listed on NDX Sweden and will be included on the list for Knock-Outs. The instruments will be registered at Euroclear Sweden AB.Issuer: BNP Paribas Arbitrage Issuance B.V. Type of security: Call and put Turbo warrants of European type Execution: Automatic cash settlement Term: As from March 03, 2017 to expiry date Market Maker: BNP Paribas Arbitrage SNC Underlying: DAX 30 Index For more details see attached file. For further information concerning this NDX notice please

There are no items matching the current filter
There are no more items matching the current filter
Back to top